Cargando…
Dose-modifying factor for captopril for mitigation of radiation injury to normal lung
Our goal is to develop countermeasures for pulmonary injury following unpredictable events such as radiological terrorism or nuclear accidents. We have previously demonstrated that captopril, an angiotensin converting enzyme (ACE) inhibitor, is more effective than losartan, an angiotensin type-1 rec...
Autores principales: | Medhora, Meetha, Gao, Feng, Fish, Brian L., Jacobs, Elizabeth R., Moulder, John E., Szabo, Aniko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393339/ https://www.ncbi.nlm.nih.gov/pubmed/22843631 http://dx.doi.org/10.1093/jrr/rrs004 |
Ejemplares similares
-
Radiation Increases Bioavailability of Lisinopril, a Mitigator of Radiation-Induced Toxicities
por: Medhora, Meetha, et al.
Publicado: (2021) -
Angiotensin Converting Enzyme Inhibitors Mitigate Collagen Synthesis Induced by a Single Dose of Radiation to the Whole Thorax
por: Kma, Lakhan, et al.
Publicado: (2012) -
Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes
por: Gasperetti, Tracy, et al.
Publicado: (2021) -
Biomarkers to Predict Lethal Radiation Injury to the Rat Lung
por: Medhora, Meetha, et al.
Publicado: (2023) -
Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes
por: Gasperetti, Tracy, et al.
Publicado: (2021)